References
- 1. https://gco.iarc.fr/today/home; last access date October 22, 2021.
- 2. J. M. Llovet, R. K. Kelley, A. Villanueva, A. G. Singal, E. Pikarsky, S. Roayaie, R. Lencioni, K. Koike, J. Zucman-Rossi and R. S. Finn, Hepatocellular carcinoma, Nat. Rev. Dis. Primers 7 (2021) Article ID 6 (28 pages); https://doi.org/10.1038/s41572-020-00240-3
- 3. A. Villanueva, Hepatocellular carcinoma, N. Engl. J. Med. 380 (2019) 1450–1462; https://doi.org/10.1056/NEJMra1713263
- 4. M. Kudo, R. S. Finn, S. Qin, K. H. Han, K. Ikeda, F. Piscaglia, A. Baron, J. W. Park, G. Han, J. Jassem, J. F. Blanc, A. Vogel, D. Komov, T. R. J. Evans, C. Lopez, C. Dutcus, M. Guo, K. Saito, S. Kraljevic, T. Tamai, M. Ren and A. L. Cheng, Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial, Lancet 391 (2018) 1163–1173; https://doi.org/10.1016/S0140-6736(18)30207-1
- 5. I. M. Moya and G. Halder, Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine, Nat. Rev. Mol. Cell Biol. 20 (2019) 211–226; https://doi.org/10.1038/s41580-018-0086-y
- 6. L. Lu, Y. Li, S. M. Kim, W. Bossuyt, P. Liu, Q. Qiu, Y. Wang, G. Halder, M. J. Finegold, J. S. Lee and R. L. Johnson, Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver, Proc. Nat. Acad. Sci USA 107 (2010) 1437–1442; https://doi.org/10.1073/pnas.0911427107
- 7. H. S. Yoon, K. Fujino, S. Liu, T. Takano and D. Tsugama, NDR/LATS-family protein kinase genes are indispensable for embryogenesis in Arabidopsis, FEBS Open Bio. (2021) 2600–2606; https://doi.org/10.1002/2211-5463.13257
- 8. S. H. Patel, F. D. Camargo and D. Yimlamai, Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis, Gastroenterology 152 (2017) 533–545; https://doi.org/10.1053/j.gastro.2016.10.047
- 9. G. Sorrentino, N. Ruggeri, A. Zannini, E. Ingallina, R. Bertolio, C. Marotta, C. Neri, E. Cappuzzello, M. Forcato, A. Rosato, M. Mano, S. Bicciato and G. Del Sal, Glucocorticoid receptor signalling activates YAP in breast cancer, Nat. Commun. 8 (2017) Article ID 14073 (14 pages); https://doi.org/10.1038/ncomms14073
- 10. M. Z. Xu, T. J. Yao, N. P. Lee, I. O. Ng, Y. T. Chan, L. Zender, S. W. Lowe, R. T. Poon and J. M. Luk, Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma, Cancer 115(19) (2009) 4576–4585; https://doi.org/10.1002/cncr.24495
- 11. S. H. Zhang and D. W. Zhou, Role of the transcriptional coactivators YAP/TAZ in liver cancer, Curr. Opin. Cell Biol. 61 (2019) 64–71; https://doi.org/10.1016/j.ceb.2019.07.006
- 12. L. Kappos, J. Antel, G. Comi, X. Montalban, P. O’Connor, C. H. Polman, T. Haas, A. A. Korn, G. Karlsson, E. W. Radue and F. D. S. Group, Oral fingolimod (FTY720) for relapsing multiple sclerosis, N. Engl. J. Med. 355 (2006) 1124–1140; https://doi.org/10.1056/NEJMoa052643
- 13. C. White, H. Alshaker, C. Cooper, M. Winkler and D. Pchejetski, The emerging role of FTY720 (Fingolimod) in cancer treatment, Oncotarget 7(17) (2016) 23106-23127; https://doi.org/10.18632/oncotarget.7145
- 14. P. Dent, L. Booth, J. L. Roberts, A. Poklepovic and J. F. Hancock, Fingolimod augments monomethylfumarate killing of GBM cells, Front. Oncol. 10 (2020) Article ID 22 (15 pages); https://doi.org/10.3389/fonc.2020.00022
- 15. L. Alinari, E. Mahoney, J. Patton, X. Zhang, L. Huynh, C. T. Earl, R. Mani, Y. Mao, B. Yu, C. Quinion, W. H. Towns, C. S. Chen, D. M. Goldenberg, K. A. Blum, J. C. Byrd, N. Muthusamy, M. Praetorius-Ibba and R. A. Baiocchi, FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death, Blood 118(26) (2011) 6893–6903; https://doi.org/10.1182/blood-2011-06-363879
- 16. G. Marvaso, A. Barone, N. Amodio, L. Raimondi, V. Agosti, E. Altomare, V. Scotti, A. Lombardi, R. Bianco, C. Bianco, M. Caraglia, P. Tassone and P. Tagliaferri, Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro, Cancer Biol. Ther. 15(6) (2014) 797–805; https://doi.org/10.4161/cbt.28556
- 17. N. Zhang, Y. Qi, C. Wadham, L. Wang, A. Warren, W. Di and P. Xia, FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy, Autophagy 6(8) (2010) 1157–1167; https://doi.org/10.4161/auto.6.8.13614
- 18. M. Qian, F. Yan, W. Wang, J. Du, T. Yuan, R. Wu, C. Zhao, J. Wang, J. Lu, B. Zhang, N. Lin, X. Dong, X. Dai, X. Dong, B. Yang, H. Zhu and Q. He, Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression, Acta Pharm. Sin. B 11(12) (2021) https://doi.org/https://doi.org/10.1016/j.apsb.2021.04.003
- 19. H. Zhu, D. D. Wang, T. Yuan, F. J. Yan, C. M. Zeng, X. Y. Dai, Z. B. Chen, Y. Chen, T. Zhou, G. H. Fan, M. Ying, J. Cao, P. Luo, X. J. Liu, Y. Hu, Y. Peng, Q. He and B. Yang, Multikinase inhibitor CT-707 targets liver cancer by interrupting the hypoxia-activated IGF-1R-YAP Axis, Cancer Res. 78 (2018) 3995–4006; https://doi.org/10.1158/0008-5472.Can-17-1548
- 20. M. Yu, Z. Peng, M. Qin, Y. Liu, J. Wang, C. Zhang, J. Lin, T. Dong, L. Wang, S. Li, Y. Yang, S. Xu, W. Guo, X. Zhang, M. Shi, H. Peng, X. Luo, H. Zhang, L. Zhang, Y. Li, X. P. Yang and S. Sun, Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation, Mol. Cell 81(6) (2021) 1216–1230; https://doi.org/10.1016/j.molcel.2021.01.010
- 21. H. Zhu, F. Yan, T. Yuan, M. Qian, T. Zhou, X. Dai, J. Cao, M. Ying, X. Dong, Q. He and B. Yang, USP10 Promotes Proliferation of Hepatocellular Carcinoma by DeubiquitiNat.ing and Stabilizing YAP/TAZ, Cancer Res. 80 (2020) 2204–2216; https://doi.org/10.1158/0008-5472.CAN-19-2388
- 22. G. M. Elisi, M. Santucci, D. D’Arca, A. Lauriola, G. Marverti, L. Losi, L. Scalvini, M. L. Bolognesi, M. Mor and M. P. Costi, Repurposing of drugs targeting YAP-TEAD functions, Cancers (Basel), 10(9) (2018) Article ID 329 (19 pages); https://doi.org/10.3390/cancers10090329
- 23. D. M. Santos, L. Pantano, G. Pronzati, P. Grasberger, C. K. Probst, K. E. Black, J. J. Spinney, L. P. Hariri, R. Nichols, Y. Lin, M. Bieler, P. Seither, P. Nicklin, D. Wyatt, A. M. Tager and B. D. Medoff, Screening for YAP inhibitors identifies statins as modulators of fibrosis, Am. J. Respir. Cell Mol. Biol. 62(4) (2020) 479–492; https://doi.org/10.1165/rcmb.2019-0296OC
- 24. Y. Liu-Chittenden, B. Huang, J. S. Shim, Q. Chen, S. J. Lee, R. A. Anders, J. O. Liu and D. Pan, Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP, Genes Dev. 26 (2012) 1300–1305; https://doi.org/10.1101/gad.192856.112
- 25. K. Vigneswaran, N. H. Boyd, S. Y. Oh, S. Lallani, A. Boucher, S. G. Neill, J. J. Olson and R. D. Read, YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma, Clin. Cancer Res. 27 (2021) 1553–1569; https://doi.org/10.1158/1078-0432.CCR-20-0018
- 26. A. V. Pobbati and W. Hong, A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy, Theranostics 10(8) (2020) 3622–3635; https://doi.org/10.7150/thno.40889
- 27. R. Pippa, A. Dominguez, D. J. Christensen, I. Moreno-Miralles, M. J. Blanco-Prieto, M. P. Vitek and M. D. Odero, Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity, Leukemia 28 (2014) 1915–1918; https://doi.org/10.1038/leu.2014.141
- 28. T. Zheng, X. Meng, J. Wang, X. Chen, D. Yin, Y. Liang, X. Song, S. Pan, H. Jiang and L. Liu, PTEN-and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice, J. Cell Biochem. 111(1) (2010) 218–228; https://doi.org/10.1002/jcb.22691
- 29. J. M. Woodcock, Y. Ma, C. Coolen, D. Pham, C. Jones, A. F. Lopez and S. M. Pitson, Sphingosine and FTY720 directly bind pro-survival 14-3-3 proteins to regulate their function, Cell Signal 22(9) (2010) 1291–1299; https://doi.org/10.1016/j.cellsig.2010.04.004
- 30. S. Basu, N. F. Totty, M. S. Irwin, M. Sudol and J. Downward, Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis, Mol. Cell 11(1) (2003) 11–23; https://doi.org/10.1016/s1097-2765(02)00776-1
- 31. X. Zhao, F. Li and K. Li, The 14-3-3 proteins: regulators of plant metabolism and stress responses, Plant Biol. (Stuttg), 23(4) (2021) 531–539; https://doi.org/10.1111/plb.13268